BCL2 and malignant colon neoplasm: In colon cancer cells, the authors found that transformer 2β (Tra2β), a splicing factor overexpressed in many cancer tissues, modulates the accessibility of the miR-204 binding site on BCL-2 3′ UTR by competitive binding, thus stabilizing BCL-2 mRNA [46].